Citius Oncology, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 100.0% | 100.0% | -8.0% |
| FY2022 | 110.2% | 110.2% | 0.6% |
| FY2023 | -121.7% | -121.7% | 3.3% |
| FY2024 | -45.8% | -45.8% | -25.1% |
| FY2025 | -55.2% | -55.2% | -24.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 100.0% | 100.0% | -8.0% |
| FY2022 | 110.2% | 110.2% | 0.6% |
| FY2023 | -121.7% | -121.7% | 3.3% |
| FY2024 | -45.8% | -45.8% | -25.1% |
| FY2025 | -55.2% | -55.2% | -24.5% |